by John Conrad | Oct 10, 2024 | Member News
Vanqua Bio has announced positive interim results from its Phase 1 clinical trial of VQ-101, a novel drug designed to treat GBA-Parkinson’s and related disorders. This breakthrough could potentially slow or even halt the progression of Parkinson’s disease,...
by John Conrad | Jul 22, 2019 | iBIO News, Policy News
On Friday, July 19, Governor Pritzker signed HB 3247, creating the Parkinson’s Disease Public Awareness and Education Act. The act provides that the Director of Public Health develop a Parkinson’s disease public awareness and education program focusing on the value of...
